Congestive Heart Failure Treatment May Offer Breakthrough

Experimental drug could be a game-changer against a disease that affects millions of Americans.
1:25 | 08/31/14

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:

{{nextVideo.title}}

{{nextVideo.description}}

Skip to this video now

Now Playing:

{{currentVideo.title}}

More information on this video
Enhanced full screen
Explore related content
Comments
Related Extras
Related Videos
Video Transcript
Transcript for Congestive Heart Failure Treatment May Offer Breakthrough
team out of camp. Big health new this is mortgage. It involves an experimental drug that doesn't have a name yet. It would do a game-changer for people with congestive heart failure. Dr. Jennifer Ashton is here with more. This is basically a weakening of the heart muscle, Dan, that leads to a hormonal domino effect. 5 million Americans have this. What is so excitexciting? It's called lcz-696. It's a combination of two drugs. Being called highly significant and clinically important by some of the country's top cardiologists. Patients on this drug had a 20% reduced risk of death from cared Yo vascular disease. As reheard, they stopped the study early because the benefit was so clear-cut. 20% is significant. Any downside? This study was funded by the maker of the drug. It had slightly fewer side effects than the traditional medication. If approved, it could be available by early 2015. Might be as much as $7 a day. That's $2500 a year. The question is, will health insurance cover it.

This transcript has been automatically generated and may not be 100% accurate.

{"id":25194763,"title":"Congestive Heart Failure Treatment May Offer Breakthrough","duration":"1:25","description":"Experimental drug could be a game-changer against a disease that affects millions of Americans.","section":"GMA","mediaType":"Default"}